Combined Silencing of MED12 and Activation of IL2 by Epigenetic Editing Enhances CAR T Anti-tumor Potency

Name: Combined Silencing of MED12 and Activation of IL2 by Epigenetic Editing Enhances CAR T Anti-tumor Potency
Start: 2027-02-03T13:30
End: 2027-02-03T13:55
Location: San Diego Convention Center

SLAS 2027 International Conference & Exhibition · 3 February 2027 · 13:30–13:55 · Ballroom 6E

Combined Silencing of MED12 and Activation of IL2 by Epigenetic Editing Enhances CAR T Anti-tumor Potency was a session at SLAS 2027 International Conference & Exhibition on 3 February 2027 in San Diego, with 1 speaker on record.

Speakers

Sean Yamada-Hunter — Speaker Assistant Professor, UCLA